GILD Financial Facts
Shares used in per share calculation - basic: 1.32BNet loss attributable to noncontrolling interest: -5M
See Full Income Statement
Deferred revenues: 361M
Retained earnings: 16.65B
See Full Balance Sheet
Gilead Sciences Inc. (GILD) Earnings
|
Expand Research on GILD
| Next EPS Date | 8/7/26 *Est. | EPS Growth Rate | -100.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +5.1% | Revenue Growth Rate | -100.0% *Last Qtr. |
| Average % Move 1-Wk after EPS | +3.5% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
4/23/26  |
Q126 | N/A | $1.89 | N/A | N/A | $6.93B | = | N/A | N/A | ||
| 2/10/26 | Q425 | $1.86 | $1.85 | +$0.01 | $7.93B | $7.68B | = |  | | Details | |
| 10/30/25 | Q325 | $2.47 | $2.15 | +$0.32 | $7.8B | $7.45B | = | | | Details | |
| 8/7/25 | Q225 | $2.01 | $1.96 | +$0.05 | $7.1B | $6.97B | = | | | Details | |
| 4/24/25 | Q125 | $1.81 | $1.77 | +$0.04 | $6.67B | $6.78B | = | | | Details | |
| 2/11/25 | Q424 | $1.90 | $1.71 | +$0.19 | $7.6B | $7.16B | = | | | Details | |
| 11/6/24 | Q324 | $2.02 | $1.51 | +$0.51 | $7.54B | $7.01B | = | | | Details | |
| 8/8/24 | Q224 | $2.01 | $1.60 | +$0.41 | $7B | $6.72B | = | | | Details |
